IL6 and hepatocellular carcinoma: This is particularly shown in hepatocellular carcinoma (HCC) whereby, the increased hepatic mRNA levels of FNDC5/irisin in HCC patients correlated with increased expression of proinflammatory markers, such as IL-6 and TNF-α.